NCT Heidelberg

Scientific Advisory Board

The Scientific Advisory Board (SAB) supports the NCT strategically on all crucial matters across locations. It advises the management boards, the Joint Steering Committee, and the NCT Directorates of Heidelberg and Dresden on all scientific and clinical matters as well as on strategic planning.

It is composed of nationally as well as internationally renowned clinicians and scientists from institutions which either combine clinical and scientific research, or which are purely research-oriented.

Members of the Scientific Advisory Board

Dr. Raymond DuBois (Chair)
Medical University of South Carolina (MUSC), USA

Prof. Robert Bristow
Manchester Caner Research Centre, the University of Manchester, UK

Prof. Ruggero de Maria
Alleanza Contro il Cancro (ACC), Italy

Prof. Alexander Eggermont
Gustave Roussy Comprehensive Cancer Centre, France

Prof. David Gonzalez de Castro

Queen’s University, Belfast, UK

Dr. Michelle Le Beau
The University of Chicago Comprehensive Cancer Center (UCCCC), the University of Chicago, USA

Prof. Claudia Lengerke
Department of Biomedicine, University Hospital Basel, Switzerland

Dr. Elaine Mardis

Nationwide Children’s Hospital, Institute for Genomic Medicine, Ohio, USA

Prof. Cornelis Melief

ISA Pharmaceuticals, the Netherlands

Prof. Radhe Mohan
MD Anderson Cancer Center, the University of Texas, USA

Prof. Michael Molls
Technische Universität München, TUM ForTe, Germany

Prof. Ulrik Ringborg
Cancer Center Karolinska, Karolinska University Hospital, Sweden

Prof. Yardena Samuels

Department of Molecular Cell Biology, the Weizmann Institute of Science, Israel

Dr. Thomas Sellers

Moffitt Cancer Center, USA

Prof. Paresh Vyas
MRC Weatherall Institute of Molecular Medicine, University of Oxford, UK